Cartherics is a biotechnology company based in Melbourne, Australia, focused on developing and delivering effective cell therapies for cancer treatment. Their research revolves around off-the-shelf, allogeneic cell therapy, which involves the use of universally compatible cells for treating patients. This approach aims to provide a more accessible and cost-effective solution to cancer treatment.

Established in 2016, the company is a collaborative effort between Hudson Institute of Medical Research, Monash University, and Monash Health, key medical and research institutions in Australia. Cartherics' experienced team of researchers and scientists work diligently to advance their cell therapy platform, striving to make a significant impact on global cancer treatment.

Connect